XML 188 R43.htm IDEA: XBRL DOCUMENT v3.21.1
SELECTED STATEMENTS OF INCOME DATA (Tables)
 12 Months Ended
Dec. 31, 2020
Income Statement Related Disclosures [Abstract]  
Schedule of Research and Development Costs, Net Research and development, net:
Year Ended December 31,
202020192018
Total costs$261,105 $232,118 $218,226 
Less - grants and participations(2,347)(2,556)(2,171)
Less - capitalization of software development costs(40,576)(35,844)(32,225)
$218,182 $193,718 $183,830 
Schedule of Financial Income (Expenses) and Other, Net Financial expenses and other, net:
Year Ended December 31,
202020192018
Financial income:
Interest and amortization/accretion of premium/discount on marketable securities, net
$17,596 $16,678 $7,521 
Interest1,543 3,855 3,778 
19,139 20,533 11,299 
Financial expenses:
Interest(7,770)(11,683)(11,204)
Debt issuance costs amortization(3,650)(2,083)(1,813)
Exchangeable Senior Notes amortization of discount(9,648)(7,153)(6,855)
Exchange rates differences(41)(1,832)(430)
Other(2,731)(2,186)(1,936)
(23,840)(24,937)(22,238)
Other (expenses) Income, net(158)(40)38 
$(4,859)$(4,444)$(10,901)
Schedule of Computation of Net Earnings Per Share
The following table sets forth the computation of basic and diluted net earnings per share:
1.Numerator:
Year Ended December 31,
202020192018
Net income to ordinary shareholders$196,346 $185,904 $159,338 
2.Denominator (in thousands):
Year Ended December 31,
202020192018
Denominator for basic net earnings per share:
Weighted average number of shares62,710 62,120 61,387 
Effect of dilutive securities:
Add - employee stock options and RSU1,611 1,682 1,785 
Warrants issued in the exchangeable notes transaction1,635 859 137 
Denominator for diluted net earnings per share - adjusted weighted average shares
$65,956 $64,661 $63,309